Telomerase-derived universal cancer peptide vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Telomerase-derived universal cancer peptide vaccine, covering 2025-01-09 to 2025-01-09. Get the full timeline:
Most recent: Clinical Trial Update: Anticancer Therapeutic Vaccination Using Telomerase-derived Universal Cancer Peptides in Glioblastoma [Phase 2]